CONTENT PREVIEW
Industry

ADEX 2017: UVision signs MOA for HERO 30 marketing, supply

18 October 2017

UVision has signed a Memorandum of Agreement with South Korea's FIRSTEC on the HERO 30 loitering munition. (UVision)UVision has signed a Memorandum of Agreement with South Korea's FIRSTEC on the HERO 30 loitering munition. (UVision)Israeli unmanned systems manufacturer UVision announced on 18 October that it had signed a memorandum of agreement (MOA) with South Korea’s FIRSTEC.

The MOA will see FIRSTEC market and supply the HERO 30 system in South Korea and follows a memorandum of understanding signed in September 2016, when the two companies agreed to market and jointly produce the HERO 30 for the South Korean market.

First unveiled at the Paris Air Show in 2015, the HERO 30 AV is the baseline short-range system in the HERO lethal loitering configuration. The system is built around a cylindrical fuselage that supports cruciform, pop-out flight and steering surfaces, and a nose-mounted electro-optic/infrared (EO/IR) seeker unit. The system is equipped with a 0.5 kg (1.1 lb) warhead and is powered by a rear-mounted electric motor that drives a pusher propeller. The HERO 30 has a maximum endurance of 30 minutes and can reach a range of 40 km.

Designed for anti-personnel operations, the system is launched from a canister and weighs approximately 3 kg, making it highly portable. The HERO family is equipped with uplink and video downlink capabilities, enabling targets to be selected manually or by using pre-programmed GPS co-ordinates. The systems can be used as either loitering munitions or retrievable ISR assets.

In addition to South Korea, the company is also understood to have been targeting other international opportunities. Raytheon is currently marketing the system in the US, with Thales also promoting it in the UK and Europe.

Want to read more? For analysis on this article and access to all our insight content, please enquire about our subscription options ihs.com/contact



(269 of 348 words)
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT